๐ $BHVN โ Biohaven Could Be the Next $MRNA (DD-ish, not financial advice, apes do your own research) NFA
$BHVN$MRNA
AI SUMMARY โ Biohaven (BHVN) is positioned as a potential high-growth biotech play similar to Moderna's trajectory, with pipeline candidates and development potential. Key risks include clinical trial failures, regulatory setbacks, competitive pressure from larger pharma, and typical biotech execution risk.
| TICKER | BHVN |
USER | u/Objective_One_435 |
| RATING |
BULLISH |
ENTRY |
$13.96
|
| POSITION |
353 sh
SYN
|
BOOK VAL |
$4938.10 |
| CURRENT |
$14.13 |
P&L % |
+1.25%
|
| CURR VAL |
$5000.00 |
P&L $ |
+61.90
|
| TICKER | MRNA |
USER | u/Objective_One_435 |
| RATING |
BULLISH |
ENTRY |
$156.70
|
| POSITION |
28 sh
SYN
|
BOOK VAL |
$4492.97 |
| CURRENT |
$145.13 |
P&L % |
-7.38%
|
| CURR VAL |
$4161.31 |
P&L $ |
-331.66
|